FDA-approved EB therapies expand options for gene replacement and wound healing, but success depends on careful wound preparation and timing, experts say.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/epidermolysis-bullosa-new-therapies-target-genetics-wound-2026a1000gyy?src=rss
Author :
Publish date : 2026-05-25 07:24:00
Copyright for syndicated content belongs to the linked Source.
